Cervical dysplasia (a precancerous lesion of the cervix, or CIN) is not cancer: it is a patch of abnormal cells, caused by human papillomavirus (HPV), that stays on the surface of the cervix. Low-grade lesions (CIN 1) usually clear up on their own and are simply monitored. High-grade lesions (CIN 2 and 3) are generally treated with a cone excision, a short procedure that treats the lesion in more than 9 out of 10 cases.
The cervix is covered by an epithelium, a thin layer of cells resting on a membrane called the basement membrane. When a high-risk human papillomavirus (HPV) persists, it can change these cells: this is called dysplasia, an intraepithelial lesion or CIN (cervical intraepithelial neoplasia).
As long as the abnormal cells stay above the basement membrane, it is not cancer. They cannot spread. Invasive cancer only develops if the basement membrane is breached, which usually takes several years. Detecting and treating these lesions during this long window is the whole purpose of screening, described on our Gynaecological cancer care page.
These lesions are common, especially in young women, and cause no symptoms: no pain, no bleeding, no discharge.
Usually through screening. In France, depending on your age, screening is based on:
The smear test is only a triage test: it flags suspicious cells (ASC-US, LSIL, ASC-H, HSIL, AGC) but does not make the diagnosis. Depending on the result, you will be offered a repeat test, an HPV test or a colposcopy. During colposcopy, the doctor examines the cervix under magnification and takes biopsies of any suspicious areas. It is the analysis of these biopsies that gives the diagnosis of CIN and its grade.
Waiting between the smear result and the colposcopy is often a source of anxiety. These lesions develop slowly, over years: a delay of a few weeks does not change the outlook.
| Biopsy result | What it means | Natural course | Usual management |
|---|---|---|---|
| CIN 1 (low grade, LSIL) | Changes limited to the lower third of the epithelium; usually reflects a temporary HPV infection. | Clears on its own in most cases; progression is rare. | Monitoring (cytology or HPV test, colposcopy depending on the case). Treatment only if the lesion persists for several years or if the colposcopy is incomplete. |
| CIN 2 (high grade, HSIL) | Changes reaching two thirds of the epithelium. | About half clear within 2 years, even more before the age of 30; some progress. | Cone excision in general. In a young woman, especially if she is planning a pregnancy, close monitoring may be offered. |
| CIN 3 (high grade, HSIL; includes what used to be called “carcinoma in situ”) | The full thickness of the epithelium is affected, without breaching the basement membrane. | Real risk of progressing to invasive cancer over several years. | Cone excision. |
For CIN 2, a meta-analysis of 3,160 women monitored without treatment showed that at 2 years, 50% of lesions had cleared, 32% persisted and 18% had progressed; in women under 30, 60% cleared. This supports active monitoring in some young women, provided strict follow-up can be ensured.
There are also glandular lesions (adenocarcinoma in situ, AIS), which are rarer and located in the cervical canal. They are always treated by cone excision.
The standard treatment is a cone excision (conisation), usually done with a diathermy loop (electric loop, also called LLETZ), under local or short general anaesthetic, as a day case. It removes the transformation zone where the lesion lies. The procedure is both:
The cone is kept as small as possible while still removing the lesion completely. The deeper the tissue removed, the higher the risk of premature birth in a later pregnancy. This is why unnecessary cone excisions are avoided, particularly for low-grade lesions.
Destructive treatments (laser, vaporisation, cryotherapy) do not allow the tissue to be analysed. They are reserved for specific situations: a fully visible lesion, no suspicion of invasion or glandular lesion, and a complete colposcopy.
After a cone excision, the risk of residual or recurrent high-grade disease is low, around 7% in a large meta-analysis. To detect it, the HPV test is more reliable than the status of the margins of the removed tissue.
HPV vaccination after treatment can be discussed depending on your age (see HPV vaccination).
Treatment removes the lesion, but the papillomavirus can sometimes persist elsewhere on the cervix, vagina or vulva. A few simple measures help limit the risk:
A weakened immune system (HIV, transplant, immunosuppressive treatment) means closer and longer follow-up. Always tell your gynaecologist about it.
The same virus can cause precancerous lesions of the vulva (VIN) or vagina (VaIN). They sometimes cause itching or a patch of changed skin, and are investigated by examination under magnification and a biopsy. Any persistent lesion of the vulva should be shown to a doctor.
An abnormal smear found during pregnancy is investigated by colposcopy. The aim is to rule out invasive cancer, which is exceptional. Precancerous lesions are almost never treated during pregnancy: they are monitored, then reassessed after the birth. A biopsy, if needed, is safe for the pregnancy.
Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.
Book an appointmentNo. It is an abnormality of the surface cells that can, in some cases and over several years, develop into cancer. Treating or monitoring it is precisely what prevents cancer.
Papillomavirus is very common and shared within couples; there is no recommended HPV screening test for men without symptoms. Your partner only needs to see a doctor if he notices a genital lesion.
No. The lesion itself has no effect on fertility. A cone excision slightly increases the risk of premature birth, especially if it is deep or repeated, and this will be taken into account during pregnancy care.
Most low-grade lesions clear on their own within one to two years. Monitoring checks that this happens without unnecessary treatment.
An abnormal smear does not mean cancer. Depending on the result and your age, you will be offered an HPV test on the same sample (ASC-US cells between 25 and 29), a repeat test, or a colposcopy with biopsies straight away (LSIL and more marked abnormalities), in line with the INCa guidelines updated in 2025.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.